What role do GluR1 subunits play in drug abuse?

Catalytic NH3 oxidation to N2 by hydrogen atom abstraction using a low-valent molybdenum complex.

Chemical communications (Cambridge, England)·2025

The Continuing Challenges of Studying Parallel Behaviours in Humans and Animal Models.

Current topics in behavioral neurosciences·2024

α4-Containing GABAA Receptors on DRD2 Neurons of the Nucleus Accumbens Mediate Instrumental Responding for Conditioned Reinforcers and Its Potentiation by Cocaine.

eNeuro·2023

CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice.

Translational psychiatry·2023

Catalytic Ammonia Oxidation to Dinitrogen by a Nickel Complex.

Angewandte Chemie (International ed. in English)·2022

Early-life stress influences acute and sensitized responses of adult mice to cocaine by interacting with GABAA α2 receptor expression.

Behavioural pharmacology·2019

Alternative splicing dysregulation in CAG repeat expansion diseases.

Trends in neurosciences·2026

An epigenetic view of anxiety disorders, one cell type at a time.

Trends in neurosciences·2026

Fronto-striatal molecular convergence in eating and obsessive-compulsive disorders.

Trends in neurosciences·2026

Translation elongation in the nervous system.

Trends in neurosciences·2026

Interleukin-6 trans-signalling as a selectively targetable driver of neurodegeneration.

Trends in neurosciences·2026

Linking sensory experience to bodily states in the insular cortex.

Trends in neurosciences·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

What role do GluR1 subunits play in drug abuse?

Related Concept Videos

Catalytic NH3 oxidation to N2 by hydrogen atom abstraction using a low-valent molybdenum complex.

The Continuing Challenges of Studying Parallel Behaviours in Humans and Animal Models.

α4-Containing GABAA Receptors on DRD2 Neurons of the Nucleus Accumbens Mediate Instrumental Responding for Conditioned Reinforcers and Its Potentiation by Cocaine.

CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice.

Catalytic Ammonia Oxidation to Dinitrogen by a Nickel Complex.

Early-life stress influences acute and sensitized responses of adult mice to cocaine by interacting with GABAA α2 receptor expression.

Alternative splicing dysregulation in CAG repeat expansion diseases.

An epigenetic view of anxiety disorders, one cell type at a time.

Fronto-striatal molecular convergence in eating and obsessive-compulsive disorders.

Translation elongation in the nervous system.

Interleukin-6 trans-signalling as a selectively targetable driver of neurodegeneration.

Linking sensory experience to bodily states in the insular cortex.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

What role do GluR1 subunits play in drug abuse?

Related Concept Videos

Related Articles